Phibro Animal Health (NASDAQ: PAHC) reported record fiscal 2026 sales and a sharp increase in adjusted EBITDA, supported by growth in its Animal Health and Mineral Nutrition businesses, the integratio
Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript